Logotype for Novacyt S.A.

Novacyt (ALNOV) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Novacyt S.A.

H1 2025 earnings summary

28 Jul, 2025

Executive summary

  • 431 purchase transactions and 519 sale transactions executed under the liquidity contract in H1 2025.

  • 228,730 shares bought for €135,502.67 and 195,320 shares sold for €119,989.44 during the period.

  • As of June 30, 2025, the liquidity account held 104,002 shares and €18,458.91 in cash.

  • Compared to December 31, 2024, share holdings increased from 70,592 to 104,002 and cash decreased from €33,678.48 to €18,458.91.

Significant events and developments

  • Shareholder approval on June 19, 2025, set a maximum buyback price of €5.00 per share, up to 10% of capital, for 18 months.

  • Liquidity contract with Invest Securities renewed, with annual remuneration of €10,000 and a two-year initial term.

  • Shares acquired may be cancelled or held as treasury shares without voting or dividend rights.

Capital allocation and financing

  • Liquidity contract allows Invest Securities to buy shares independently, with no direct company communication.

  • The contract is governed by French law and can be terminated by either party with two months' notice at the end of each period.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more